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Abstract__ This review article is an update on the previous article published on Nigella 
sativa Linn in this journal in 1999.  It covers the medicinal properties of Nigella sativa 
and chemical syntheses of the alkaloids isolated from the seeds of the herb. 
 
1.0  INTRODUCTION 
The chemical composition and biological properties of Nigella sativa L. have previously 
been reviewed [Khan, 1999; Paarakh, 2010; Ahmad A, et. al., 2013]. In the previous 
review (Khan, 1999) were reported the large variety of organic compounds that are 
present in the seeds of Nigella sativa L. The seeds of this herb are used in the Middle 
East and South Asian countries for the treatment of a large variety of ailments and are 
accepted as a panacea.  For example, the seeds or oil from the seeds have been used to 
control diabetes, hypertension, cancer (leukeamia, liver, lung, kidney, prostate, breast, 
cervix, skin), inflammation, hepatic disorder, arthritis, kidney disorder, cardiovascular 
complications and dermatological conditions (Khan et al., 2011; Khan et al., 2003b). A 
GC-MS analysis of the seed extract has shown it to be a mixture of eight fatty acids and 
32 volatile terpenes. The major terpenes, thymoquinone (TQ), dithymoquinone (DTQ), 
trans-anethol, p-cymene, limonine, and carvone have been identified (Nickavar et al., 
2003). TQ and DTQ are both cytotoxic for various types of tumors (Worthen et al., 1998). 
In addition diterpenes, triterpene and terpene alkaloids have been identified in Nigella 
sativa seeds. The methanolic extract of the seeds contain two types of alkaloids whilst 
the major principal active ingredient isolated from the volatile oil of Nigella sativa L. is 
TQ. Since Nigella sativa L. acts as a panacea exhibiting a wide variety of pharmacological 
actions discussed previously and updated in this report, interest has arisen in the total 
synthesis of the alkaloids isolated having the isoquinoline and indazole motifs. The  
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 isoquinoline alkaloids include nigellicimine (1) and nigellicimine- N-oxide (2), and the 
indazole alkaloids include nigellidine (3) and nigellicine (4) (Fig. 1). Since the previous 
review several new dolabellane-type diterpene alkaloids, nigellamines A1-A5 (5) have 
also been isolated from the methanolic extract of the seeds of Nigella sativa L. which 
have also received synthetic interest (Fig. 1). In this update on Nigella sativa we want to 
discuss the chemistry of these various alkaloids and TQ under separate headings. 
 
 
Figure 1. Structures of alkaloids isolated from Nigella sativa L. 
1.1  Pyrazole and Indazole ring systems 
 
 
Figure 2.  Types of indazole ring compounds 
Indazole and pyrazole motifs are embedded in numerous pharmaceuticals and 
agrochemicals with a broad range of biological activities  such as (6) (Penning et al, 
1997), (7) (Plosker and Goa, 1991), (8) (de Paulis et al, 2006), (9) (Okuno et al, 2004), 
(10) (Maxwell, 2000) and (11) (Lahm et al, 2009) shown in  Figure 3.  
 
 
 
Figure 3.  Structures of some pharmaceuticals and agrochemicals with indazole and 
pyrazole motifs 
 
 
As a result of these biological activities being associated with the presence of pyrazole 
and indazole pharmacore in therapeutic compounds, the two indazole alkaloids 
nigellidine (3) and nigellicine (4) have attracted the attention of synthetic organic 
chemists for their total syntheses. Thus multigram quantities of these two alkaloids can 
now be obtained via their total syntheses that should enable their individual 
therapeutic evaluation to be possible. 
 
 
 
2.0 CHEMISTRY OF THE ALKALOIDS AND TQ IN Nigella sativa 
 
2.1  Total synthesis of  Nigellidine (3) 
The development of an efficient synthetic method using Pd(II)/Phen catalyst and 
conditions for the direct C-3 C-H arylation of (1H) indazole and pyrazole with ArI or 
ArBr was applied to the synthesis of nigellidine as shown in scheme 1 (Ye et al, 2013). 
The THP derivative of the commercially available 4-methoxy-6-methyl-(1H)-indazole 
was reacted with 4-bromoanisole using the C-3 arylation reaction as a key step to form 
the adduct (14) in 54% isolated yield on the gram scale. Deprotection of the  
tetrahydropyranyl (THP) group gave (15) which N-alkylation with 1,4-dibromobutane 
to afford (16) that underwent intramolecular cyclised to furnish the precursor (17). 
Demethylation of (17) by treatment with BBr3 afforded the natural product nigellidine 
(3) as the hydrobromide salt in an overall yield of 18%. 
2.2  The Total synthesese of Nigellicine (4) 
To date there have been two total syntheses of nigellicine reported. In the first synthesis 
shown in scheme 2 commercially available 2-chloro-5-methylphenol (17) was 
transformed into the protected amide (10) which on lithiation and acylation with 
diethyloxalate yielded the amide-ester (20) that cyclised on treatment with 6MHCl acid 
into the isatin (21) (Elliott et al, 2005). Protection of the keto group in isatin (21) as the 
dimethyl acetal (22) enabled direct amination at nitrogen to give the hydrazine 
derivative (22) which on treatment with aqueous acid rearranged into an indazole 
carboxylic acid that was esterified via an acid chloride into (23). Alkylation of indazole 
ester (23) with 1,4-dibromobutane and subsequent intramolecular cyclisation produced 
a 4-methoxy derivative of nigellicine which was deprotected with PBr3 to give 
nigellicine in an overall yield of 18%.  
The second total synthesis of nigellicine (4) shown in scheme 3 starts with 
commercially available 2,5-dimethylphenol (24) which was converted into 2-bromo-6-
methoxy-4-methylbenzaldehyde ȋ25Ȍ by Clive’s method (Inamoto et al, 2007). 
Treatment of aldehyde (25)  with KCN and ethyl chloroformate in the presence of 
benzyltrimethylammonium chloride (BTAC) and 18-crown-6 in a mixture of water and 
1,2-dichloroethane produced an intermediate cyanohydrin carbonate ester which was 
subsequently converted to a-ketoester (26) by LiHMDS-induced rearrangement. The 
reaction of (26) with p-toluenesulfonyl hydrazide gave the key intermediate hydrazone 
(27) as a mixture of E- and Z-isomers, which was separable by column chromatography 
to obtain the major trans isomer that was subsequently converted by Pd-catalysed 
cyclisation to the indazole (28). Alkylation of the deprotected compound (29) with 1,4-
dibromobutane produced the intermediate (30) which underwent intramolecular 
cyclisation in hot ethanol to furnish the nigellicine ethyl ester hydrobromide salt (31). 
Finally treatment of ester (31) with PBr3 caused cleavage of the ester group and 
deprotection of the methoxy group to give nigellicine (4). 
 
2.3  Total synthesis of Nigellamine A2 (5b)  
The delabellane diterpenes are ubiquitous molecules that are produced by animals, 
plants, fungi  and marine sources and have interesting array of biological activities. The 
alkaloids nigellamines A1-A5  which have been isolated from Nigella sativa L. belong to 
the delabellane family of diterpenes and show potent lipid metabolism-promoting 
activity (Morikawa et al, 2004a). These biologically active alkaloids  have complex 
structural features and have attracted the attention of synthetic organic chemists for 
their total synthesis. 
 
  
 
  
One enantioselective total synthesis of nigellamine A2 has so far been reported (Bian et 
al, 2006). In this synthesis shown in scheme 4 the starting lactone-diene (32) was 
transformed in three steps and on on multigram scale into the allylic ester (33) as a key 
intermediate. Iodolactonisation of diene (33) produced (34) which on radical 
alkynylation furnished the propynyl lactone (35). Desilylation and reduction of (35) 
yielded the propynyl lactol (36) which upon in situ iodination and subsequent silylation 
afforded the vinyl iodide (37) in good yield. The remaining carbon atoms of the 
nigellamine skeleton were constructed  through cross coupling with alkyl zinc reagent 
and a repeat methylalumination-iodination sequence of reactions to afford substrate 
(38). Oxidation with pyridinium chlorochromate (PCC) gave an aldehyde at position C2 
which upon sonification underwent Cr-mediated cyclisation with the vinyl iodide group 
at position  
  
C3 to generate the 11-membered compound (39). Reductive opening of the lactone and 
selective acylation of the primary alcohol gave the substrate (40). Oxidation of (40) with 
Shi's ketone catalyst and oxone proceeded region- and stereoselectively to produce the 
desired epoxide-diol as the major product which was acylated with nicotinic acid to 
furnish ent-nigellamine A2 (5b).   
 
2.4  Novel synthetic Thymoquinone analogues 
The compound 5-isopropyl-2-methyl-1,4-benzoquinone is known as thymoquinone 
(TQ) (41) shown in scheme 5. TQ is the major active principle of the oil of Nigella sativa 
L. and has been shown to exhibit anti-tumor activity against breast, lung, prostrate, liver, 
colon and pancreatic cancer. Thus interest has arisen to synthesise more potent 
analogues of TQ. Recently reported are the novel analogues of TQ consisting of 
compounds (44a-b) were synthesised in two steps from TQ Sodium azide added to TQ 
in acetic acid to afford the reduced product (42) which on reaction with the aldehydes 
(43a-b) generated the Schiff bases (44a-b) (Yusufi et al, 2013). These analogues have 
shown superior proliferative activity, excellent chemo-sensitizing activity against 
pancreatic cancer in vitro and in combination with Gemcitabine. 
 
 
One serious drawback with TQ is its toxicity at high doses and poor water solubility 
which limit its usage as a therapeutic agent. In order to alleviate this problem various 
types of nanocarrier for thymoquinone have been synthesised (Ravindran et al, 2010; 
Ganea et al, 2010; Alam et al, 2012; Singh et al, 2013). One recent study has reported the 
synthesis of PAG coated NIPAAM nanoparticles that are encapsulated with TQ for direct 
hepato-targeting. NIPAAM is a thermosensitive nanopolymer which is widely used as a 
successful drug delivery system against various diseases and PAG is a galactosylated 
moiety that targets the liver by interacting with asialoglycoprotein receptor (ASGP-R) 
present on the surface of hepatocytes and delivers the drug directly to the liver (Verma 
et al, 2013). The toxicity of the nanocarrier (NIPAAM) at this concentration is almost 
negligible and due to the size of the nanoparticle being smaller than the already 
reported nanothymoquinone.  
 
 
This study clearly has demonstrated that the nanoparticles are able to carry bulk 
amounts of drug to the liver, and their direct targeting to ASGP-R receptors present on 
hepatocytes has resulted in significant hepatoprotection at a low dose level  that is 1000 
times lower than the naked TQ. This nanocarrier  approach offers a promising prospect 
for the future against various liver diseases.  
 
3.0 BIOLOGICAL ACTIVITIES OF Nigella sativa 
3.1 The anti-inflammatory activities  
In animal studies Nigella sativa shows dose-dependent suppression of nociceptive pain 
response and cestocidal activity. These activities are shown by TQ that acts through 
indirect activation of the supraspinal mu(1)- and kappa-opioid receptor subtypes 
(Abdel-Fattah et al., 2000; Akhtar et al., 1991).  The antihypertensive principal TQ and 
other constituents of Nigella sativa are also protective agents against the chromosomal 
aberrations induced by schistosomiasis (Aboul-Ela, 2002; el el Tahir et al., 1993a). 
These compounds are used in the control of arterial blood pressure, anticholinergic, 
antihistaminic, tracheal relaxation, control of asthma and in the treatment of other 
allergic diseases (Ahmed et al., 2013; Al-Majed et al., 2001; Boskabady et al., 2004; Kalus 
et al., 2003; Steinmann et al., 1997).   
                                          
 Figure 4.  Chemical structures of principal active ingredient isolated from the volatile 
oil of Nigella sativa L 
Nigellone (dithymoquinone) is the carbonyl dimer of TQ present in Nigella sativa and it 
inhibits the release of histamine giving relief in asthmatic conditions (Chakravarty, 
1993; el Tahir et al., 1993b). The spasmolytic and bronchodilator activities of Nigella 
sativa are mediated possibly through calcium channel blockade (Gilani et al., 2001). 
Physologically important activities shown by Nigella sativa include analgesic, anti-
inflammatory, antimicrobial, antifungal and antibacterial effects (Hanafy et al., 1991; 
Khan et al., 2003a; Morsi, 2000) and CNS activity of its aqueous extract and volatile oil 
components (Al-Ghamdi, 2001; Al-Naggar et al., 2003; Hajhashemi et al., 2004; Haq et al., 
1995).  The neuroprotective activity of Nigella sativa on neurotransmitter leading to 
antiepileptic activity has also been described (Arafa et al., 2013). TQ, through an opioid 
receptor-mediated, increases in GABAergic tone, exhibits anticonvulsant activity in the 
petit mal epilepsy (Hosseinzadeh et al., 2004). 
 
3.2 Antiulcer and anticancer properties  
Ethanol induced ulcer in rats has been reduced by Nigella sativa extracts (El-Dakhakhny 
et al., 2000a). Ischaemia/reperfusion are linked by free radical generation and this 
could be controlled by an administration of TQ which could offer gastroprotective 
effects against gastric lesions (El-Abhar et al., 2003). The chemosensitising effect of TQ 
in the treatment of 5-Fluorouracil induced gastric cancer has been reported (Lei et al., 
2012). 
 
3.3 Hepato-protective antioxidant activities 
The aqueous extract of Nigella sativa (NS) is hepato-protective against carbon 
tetrachloride induced oxidative hepatic damage suggesting powerful antioxidative 
properties of NS extract (Al-Ghamdi, 2003; el-Dakhakhny et al., 2000a; Mansour et al., 
2001; Meral et al., 2003). NS protects liver by inhibiting enzyme leakage from 
hepatocytes caused by toxic substances such as carbon tetrachloride (Kanter et al., 
2003a). Through its antioxidant action, TQ is known to inhibit 5-lipoxigenase and 5-
hydroxy-eicosatetraenoic acid (5-HETE) products suggesting its use in inflammatory 
pathogenesis (El-Dakhakhny et al., 2002a). Hyperhomocysteinemia (HHcy) has been 
linked with oxidative stress. Therefore, NS has been demonstrated to improve total 
antioxidant status in rats treated with methionine induced HHcy (El-Saleh et al., 2004). 
The oxygen free radical generated by gentamicin pathogenesis causing hepatotoxicity 
and nephrotoxicity are quenched by oil and seeds of NS (Ali, 2004) and the ethanolic 
extracts of NS have the potential to protect against gama-radiation induced oxidative 
damage (Rastogi et al., 2010). It has been reported that TQ inhibits the leakage of 
hepatic enzymes and the intracellular depletion of  GSH protecting liver (Daba et al., 
1998).  
 
3.4 Immunomodulatory effect 
NS has established immunosuppressive and cytotoxic properties (Islam et al., 2004) and 
the pharmacological and therapeutical properties of NS have been reviewed by many 
workers (Ahmad et al., 2013; Ali et al., 2003; Swamy et al., 2000). The splenocyte 
proliferation, macrophage function, and NK anti-tumor activity of NS have revealed the 
potent immunomodulatory properties of the Nigella seeds (Majdalawieh et al., 2010).  
The NS seed oil also shows hepatoprotective action against hypervitaminosis A and 
humoral immune responses and non-specific cellular immune responses (Al-Suhaimi, 
2012; Al-shatwi, 2014). The immune modulating effect of NS is mediated through direct 
stimulation of macrophage phagocytic activity or lymphocytes activation (Fararh et al., 
2004; Haq et al., 1999).  
NS is a known immune stimulant that protects against many pathological conditions 
(Corder et al., 2003; Fararh et al., 2004). Thus, the powerful antioxidative and protective 
properties of TQ in proteinuria and hyperlipidemia associated with nephrotic syndrome 
have been evaluated (Badary et al., 2000). Along with TQ and other terpenoid 
compounds such as carvacrol, trans-anethole and 4-terpineol with antioxidant 
properties have been reported for NS (Burits et al., 2000). Carvacrol is a known 
inhibitor of human neutrophil elastase and may be useful agent in phytotherapy for 
injuries such as chronic obstructive pulmonary disease and emphysema (Kacem et al., 
2006). The volatile NS oil shows anti-oxytocic and sperm characteristics due to its 
antioxidant activities (Mansour et al., 2013; Aqel et al., 1996).  
 
3.5 Effect on Blood sugar and lipid profile 
Streptozotocin (STZ) treated animals respond to NS extracts with normalizing blood 
glucose through extrapancreatic actions rather than by stimulated insulin release and 
ascertain to be protective against type-2 diabetes (El-Dakhakhny et al., 2002b; Fararh et 
al., 2004; Fararh et al., 2002; Hawsawi et al., 2001). The significant increase in lipid 
peroxidation by STZ is also controlled by NS  and has protective effect in diabetes by 
decreasing oxidative stress and regeneration/proliferation of the beta-cells in the islets 
of Langerhans (Kanter et al., 2004; Kanter et al., 2003b). A petroleum ether extract of NS 
exhibits insulin-sensitizing activity (Le et al., 2004) and the mechanism of NS extract in 
the control of diabetes has ben shown to be through controlled insulin release (Rchid et 
al., 2004). At the same time, amendment in the blood lipids profile has been suggested 
by the use of NS extracts (El-Dakhakhny et al., 2000a). Arachidonic acid induced blood 
platelet aggregation and blood coagulation are inhibited by NS indicating its potential 
use in thrombosis (Enomoto et al., 2001). TQ is involved in the inhibition of arachidonic 
acid generated eicosanoids and lipid peroxidation (Houghton et al., 1995). 
 
 
3.6 Effect on arthritis  
In human, TQ has been shown to be effective in rheumatoid arthritis (Gheita et al., 
2012). Inhibition of arachidonic acid generated eicosanoids (thromboxane B2, 
leukotriene B4) supports the use of NS for the treatment of rheumatoid arthritis and 
other inflammatory diseases (Houghton et al., 1995). TQ has been implicated in bone 
healing in an animal model (Kirui et al., 2004). Inhibition of leukotrienes through 5-
lipoxygenase and LTC4 synthase activities in eicosanoid pathway has been well 
documented (Mansour et al., 2004). 
 
3.7 Anticancer Activity of  TQ 
A number of antitumor compounds have been identified from NS. These compounds are 
TQ, alpha-hederin a triterpene, isopropylmethylphenols and dollabelane-type diterpene 
alkaloid nigellamine A3, A4, A5 and C (Kumara et al., 2001; Michelitsch et al., 2004; 
Morikawa et al., 2004a; Morikawa et al., 2004b). Thus, numerous types of cancers such 
as Ehrlich ascites carcinoma (EAC), Dalton's lymphonia ascites (DLA) and Sarcoma-180 
(S-180) cells, colon carcinoma, pancreatic carcinoma and hepatic carcinoma have been 
treated with NS extracts in vitro (Salomi et al., 1992; Samarakoon et al., 2010). Changes 
in intracellular GSH and redox status for mitochondrial function are important factors in 
the mechanism of alpha-hederin induced cell death (Swamy et al., 2003).  
   
 
The NS extract exerts anti-hepatocarcinoma effect through modulation of apoptosis 
(Samarakoon et al., 2012). The regulation of pro- and anti apoptic genes by NS has been 
demonstrated in treating cervical cancer (Shafi et al., 2009). In many cases the 
antitumor activity of NS seeds has been attributed to the volatile component 
thymoquinone (structurally related to  tert-butylhydroquinone, a potent antioxidant) 
that has the potential to protect rat liver against diethynitrosamine (DEN) induced 
hepatocarcinogenesis (Iddamaldeniya et al., 2003). It also improves the therapeutic 
efficacy of ifosfamide by decreasing nephrotoxicity and improving antitumor activity 
(Badary, 1999; Saleem et al., 2012).  
TQ also affects the benzo-a-pyrene induced clastogenic activity in rats and 20-
methylcycloanthrene induced fibrocarcinoma is inhibited by TQ present in NS extracts 
(Badary et al., 2007; Badary et al., 2001). While supplementation by NS and honey in the 
treatment of methylnitrosourea induced inflammation, carcinogenesis and oxidative 
stress has been reported (Mabrouk et al., 2002), the lipid peroxidation induced liver 
damage in diabetic rats has also been mentioned (Meral et al., 2001).  
The pro-oxidant nitric oxide production is inhibited by NS extracts validating the fact 
that NS has anti-inflammatory activities (Mahmood et al., 2003).  Model in vivo 
experiments with Schistosomiasis mansoni infected mice have concluded that NS 
extract have a great protective potential against oxidative stress protecting liver 
(Mahmoud et al., 2002). The mode of action of TQ against cancer has been suggested to 
be through its antioxidative properties and interaction with DNA synthesis. The 
antioxidant and pro-oxidant properties of TQ have been substantiated by augmented TQ 
mediated scavenging of superoxide anion (Badary et al., 2003). However, presence of 
the phenolic compounds in NS, such as vanillic acid, could also contribute to the 
antioxidant properties of NS. These compounds may also be responsible for its 
antimutagenic activities (Bourgou et al., 2008; Khader et al., 2010). TQ exhibits 
advanced antimyeloma activity in MDN and XD2 multiple myeloma malignant plasma 
cells (Badr et al., 2011).  However, the mechanism of chemotaxis of malignant plasma 
cells is not well defined. 
 
 
3.8 Effect of TQ on Pancreatic carcinoma (PC) 
 PC is one of the most deadly cancers with almost invariably fatal consequences. TQ has 
antitumor activity against PC. To combat PC, the dose of TQ has to be high. Therefore, 
many attempts have been made to study structure activity relationships by synthesizing 
TQ analogs and some of these compounds have potent antitumor activity against PC 
(Banerjee et al., 2010). Gemcitabine- or oxaliplatin-induced activation of NF-kappaB is 
inhibited by TQ, resulting in the chemosensitization of pancreatic tumors to 
conventional therapeutics (Banerjee et al., 2009). Progressive apoptosis is also inhibited 
by NS (Corder et al., 2003).  
 
3.9 Co-administration of NS with other substances  
Cisplatin is a widely used drug that induces kidney toxicity. It has been established that 
when cisplatin is co-administered with NS, the nephrotoxicity is reduced (El-Daly, 1998; 
Nair et al., 1991; Ulu et al., 2012).  A co-administration of NS with green tea extract 
prevents cytotoxicity of organophosphorus compounds (Korany et al., 2011). Co-
administration of saffron with NS in the treatment of chemical carcinogenesis has also 
been reported (Salomi et al., 1991). 
 
4.0 Breast Cancer 
 It is one of the most common causes of death in women and there is no effective 
treatment except mastectomy.  Many substances have been shown to have mammary 
anticancer activity and among these are melotonin and retinoic acid. NS has been 
examined in animals exposed to 7,12-di-methylbenz(a)anthracene (DMBA), mammary 
cancer causing substance which showed NS reduces the carcinogenic effects of DMBA 
(El-Aziz et al., 2005). Inactivation of MCF-7 breast cancer cells has been demonstrated 
by NS extracts (Farah et al., 2003). 
 
 
4.1 Colon Cancer 
 The molecular mechanism of action of TQ in colon cancer has been suggested. Thus, 
colon cancer is inhibited in G1 phase cell cycle and apoptosis is mediated by TQ (Gali-
Muhtasib et al., 2004). The 1,2-dimethylhydrazine (DMH), colon cancer inducer, damage 
erythrocytes has been reported and NS has the ability to detoxify DMH (Harzallah et al., 
2012; Worthen et al., 1998). The preneoplastic lesions for colon cancer have been 
investigated and found that colon cancer in post-initiation stage can be prevented by 
volatile components of Nigella seeds (Salim et al., 2003). 
 
5.0  Conclusion 
The Islamic claim made by prophet Muhammad over 1400 years ago that "black seed 
(Nigella sativa Linn.) has the cure for all deseases" has a much more meaningful and 
acceptable dimension to it given the overwhelming scientific data obtained, as outlined 
in the reviews, that supports it. The alkaloids present in Nigella sativa Linn. could now 
be obtained by total synthesis and the study of their pharmacological properties should 
make very interesting research studies for the future. 
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